Cornercap Investment Counsel Inc Dyne Therapeutics, Inc. Transaction History

Cornercap Investment Counsel Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$8.6 - $12.18 $2,554 - $3,617	-297 Reduced 1.4%	20,938 $187,000
Q2 2023 Aug 11, 2023	BUY	$8.53 - $14.28 $181,134 - $303,235	21,235 New	21,235 $238,000
Q3 2022 Nov 14, 2022	SELL	$7.2 - $15.17 $29,160 - $61,438	-4,050 Reduced 14.65%	23,601 $300,000
Q2 2022 Aug 15, 2022	BUY	$4.36 - $10.5 $120,558 - $290,335	27,651 New	27,651 $190,000

210

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.55B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.